Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,045
Closed -$332K 28
2023
Q2
$332K Buy
+3,045
New +$325K 0.02% 742
2023
Q1
Sell
-2,170
Closed -$238K 1191
2022
Q4
$238K Sell
2,170
-37,220
-94% -$3.85M 0.01% 1000
2022
Q3
$3.81M Sell
39,390
-78,762
-67% -$8.39M 0.13% 163
2022
Q2
$12.8M Buy
+118,152
New +$13.4M 0.38% 64
2021
Q2
Sell
-140,198
Closed -$16.8M 1457
2021
Q1
$16.8M Buy
140,198
+29,218
+26% +$3.46M 0.52% 47
2020
Q4
$12.2M Buy
+110,980
New +$12.1M 0.4% 62

Other funds holding ABT

Ergoteles's ABT Position: Q3 2023 in Review

Ergoteles sold out of Abbott (ABT) in Q3 2023, closing a stake of 3,045 shares — an estimated $332K sold.

Ergoteles first reported a position in ABT in Q4 2020 and held it in 6 quarters. The position peaked at $16.8M in Q1 2021. 2,681 funds tracked by Wall St. Rank hold ABT as of Q3 2023.

  • Ergoteles reported no remaining Abbott position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 3,045 Abbott shares in Q3 2023, an estimated $332K.
  • Ergoteles first reported a position in Abbott in Q4 2020 and held it in 6 quarters.
  • Ergoteles's Abbott position peaked at $16.8M in Q1 2021.
  • 2,681 funds tracked by Wall St. Rank held Abbott as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.